South San Francisco, CA, United States of America

Richard Pastor

This inventor holds 24 USPTO granted patents and 18 published patent applications, plus 1 CIPO patent and 13 EPO patents, primarily in Pharmaceutical Inhibitors. Top assignees: Genentech, Inc., Constellation Pharmaceuticals, Inc., Newlink Genetics Corporation. Active years: 2002-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Richard Pastor. Retrieved from https://idiyas.com/inventor/richard-pastor

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 24 (Patent Applications = 18)

% Patents Active = 66.7

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 13 (Patent Applications = 18)

Average Co-Inventor Count = 9.0

ph-index = 4

Forward Citations = 58(Granted Patents)

Location History:

San Francisco, CA (US) (2002 - 2016)
South San Francisco, CA (US) (2017 - 2023)

Company Filing History:

Constellation Pharmaceuticals, Inc.

patents

3 out of 22

Newlink Genetics Corporation

patents

4. 1 out of 946

Gilead Sciences, Inc.

patents

where one patent can have more than one assignee

Years Active: 2002-2026

Loading Chart...

Areas of Expertise:

TDO2 Inhibitors

Cyclic Peptide Antibiotics

JAK Inhibitors

Interleukin-1 Activity

USP7 Inhibitors

Serine Protease Inhibitors

Sulfonimidamide Compounds

Therapeutic Compounds

Triazolopyridine Compounds

Pyrazolopyrimidine Compounds

Amidine Inhibitors

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12583858 - TDO2 inhibitors (2026-03-24),

2. 12358951 - Cyclic peptide antibiotics (2025-07-15),

3. 12234245 - Sulfonimidamide compounds as inhibitors of interleukin-1 activity (2025-02-25),

4. 11827639 - TDO2 and IDO1 inhibitors (2023-11-28),

5. 11603373 - TDO2 and IDO1 inhibitors (2023-03-14),

6. 11560391 - Sulfonylurea compounds as inhibitors of interleukin-1 activity (2023-01-24),

7. 11279735 - Cyclic peptide antibiotics (2022-03-22),

8. 10800780 - TDO2 Inhibitors (2020-10-13),

9. 10358437 - Therapeutic compounds and uses thereof (2019-07-23),

10. 10280149 - Therapeutic compounds and uses thereof (2019-05-07),

11. 10206931 - Therapeutic compounds and uses thereof (2019-02-19),

12. 10155764 - Therapeutic compounds and uses thereof (2018-12-18),

13. 9763922 - Therapeutic compounds and uses thereof (2017-09-19),

14. 9573899 - USP7 inhibitor compounds and methods of use (2017-02-21),

15. 9434732 - Triazolopyridine JAK inhibitor compounds and methods (2016-09-06),

Title: The Innovative Journey of Richard Pastor

Introduction: Richard Pastor, a visionary inventor based in South San Francisco, CA, has made significant contributions to the field of technology with his groundbreaking inventions and patents.

Latest Patents: Richard Pastor holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing his diverse range of expertise and innovative spirit.

Career Highlights: With a career spanning over two decades, Richard Pastor has worked with leading tech companies, research institutions, and universities to develop cutting-edge technologies that have revolutionized various industries.

Collaborations: Throughout his career, Richard Pastor has collaborated with top scientists, engineers, and researchers to bring his ideas to life, fostering a culture of innovation and creativity in every project he undertakes.

Conclusion: Richard Pastor's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and entrepreneurs, leaving a lasting impact on the world of technology.

Profile summary based on public USPTO records.